Malik’s ‘Anti-Woke’ 1789 Capital Bets on Startup BlinkRx (1)

Nov. 15, 2024, 7:06 PM UTC

Omeed Malik’s 1789 Capital, which counts Donald Trump Jr. as its latest hire, led a funding round for BlinkRx, a startup that aims to provide low-cost prescription medication to consumers, according to people with knowledge of the matter.

Palm Beach, Florida-based 1789, which seeks to invest in conservative-leaning companies, is leading the $140 million round, which values BlinkRx at roughly $2 billion, said the people, who asked not to be identified discussing confidential information. Fidelity Investments, Joe Lonsdale’s 8VC, the late Paul Allen’s Cercano Management and Sweetwater Private Equity also invested in the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.